Cite
Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients.
MLA
Roé, Esther, et al. “Description and Management of Cutaneous Side Effects during Cetuximab or Erlotinib Treatments: A Prospective Study of 30 Patients.” Journal of the American Academy of Dermatology, vol. 55, no. 3, Sept. 2006, pp. 429–37. EBSCOhost, https://doi.org/10.1016/j.jaad.2006.04.062.
APA
Roé, E., García Muret, M. P., Marcuello, E., Capdevila, J., Pallarés, C., & Alomar, A. (2006). Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. Journal of the American Academy of Dermatology, 55(3), 429–437. https://doi.org/10.1016/j.jaad.2006.04.062
Chicago
Roé, Esther, María Pilar García Muret, Eugenio Marcuello, Jaume Capdevila, Cinta Pallarés, and Agustín Alomar. 2006. “Description and Management of Cutaneous Side Effects during Cetuximab or Erlotinib Treatments: A Prospective Study of 30 Patients.” Journal of the American Academy of Dermatology 55 (3): 429–37. doi:10.1016/j.jaad.2006.04.062.